insights_auto
Why is HALO up 13,02%?
Dive Deeperchevron_right
HALO:BMV
Halozyme Therapeutics, Inc.
2 225,00 MX$
arrow_upward
+13,02%(+256,31) 1D
15 қаз., 14:00:00 GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Open
2 225,00 MX$
High
2 225,00 MX$
Low
2 225,00 MX$
Mkt. cap
13,79 млрд
Avg. vol.
440,00
Volume
50,00
52-wk high
2 225,00 MX$
52-wk low
1 126,00 MX$
No. of employees
423
Open
2 225,00 MX$
High
2 225,00 MX$
Low
2 225,00 MX$
Mkt. cap
13,79 млрд
Avg. vol.
440,00
Volume
50,00
52-wk high
2 225,00 MX$
52-wk low
1 126,00 MX$
No. of employees
423
News stories
From web sources and news partners
CNBC
·
4 сағат бұрын
Inside Edge’s Todd Gordon: Halozyme Therapeutics are beating estimates; raised full-year guidance
Yahoo Finance
·
11 сағат бұрын
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
Timothy Sykes
·
1 күн бұрын
HALO Stock Climbs As Dutch Court Injunction Lifts Bullish Bets
StocksToTrade
·
1 күн бұрын
HALO Stock Climbs As Patent Win And Deals Lift Outlook
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
HeadquartersСан-Диего, Калифорния, Америка Құрама Штаттары
Sector-
Websitehalozyme.com